中文
Announcement
More
Progress in Chemistry 2018, Vol. 30 Issue (12): 1827-1835 DOI: 10.7536/PC180227 Previous Articles   Next Articles

• Review •

Synthesis of Homoharringtonine and Harringtonine

Yu Dong, Haibo Li, Jin Li, Lei Feng, Zhiwei Zhang*   

  1. College of Chemical and Pharmaceutical Engineering, Key Laboratory of Molecular Chemistry for Drug of Hebei Province, Hebei University of Science and Technology, Shijiazhuang 050018, China
  • Received: Revised: Online: Published:
  • Supported by:
    The work was supported by the National Natural Science Foundation of China(No. 21302039) and the Natural Science Foundation of Hebei Province(No. B2016208124).
PDF ( 501 ) Cited
Export

EndNote

Ris

BibTeX

Natural drugs homoharringtonine and harringtonine are minor alkaloids isolated from the leaves and stems of plum yew Cephalotaxus harringtonia, an evergreen tree native of the southern provinces of China. Structurally, two natural drugs are all chiral compounds and have a common skeleton cephalotaxine, and the ester side chains bear chiral tertiary alcohol at α position. Because of the formidable steric bulk of both the keleton cephalotaxine and ester side chain, the esterification of both sections is extremely challenging. A less hindered side chain intermediate is key element to success for this coupling reaction. Consequently, chemists continuously designed and synthesized structurally diverse side chain intermediates such as α-ketoacids, four-membered lactone heterocycles, tetrahydrofuran heterocycles, tetrahydropyran heterocycles, and seven-membered lactone heterocycles, enabling the completion of synthesis of homoharringtonine, harringtonine and other related natural products. Based on our studies toward the synthesis of Cephalotaxus alkaloids, this paper reviews the strategic development towards the synthesis of Cephalotaxus natural drugs and other products by the types of side chain intermediates, including not only recent strategy advances but also synthetic methods developed by respected older generation chemists.
Contents
1 Introduction
2 Synthesis of homoharringtonine
2.1 α-Ketoacids as coupling partners
2.2 Tetrahydropyran intermediate as coupling partner
2.3 Four-membered lactone intermediate as coupling partner
3 Synthesis of harringtonine
3.1 α-Ketoacid as coupling partner
3.2 Dihydrofuran intermediate as coupling partner
3.3 Seven-membered lactone intermediate as coupling partner
4 Synthesis of anhydroharringtonine
4.1 α-Ketoacid as coupling partner
4.2 Tetrahydrofuran intermediate as coupling partner
5 Synthesis of homodeoxyharringtone
5.1 α-Ketoacid as coupling partner
5.2 Four-membered lactone intermediate as coupling partner
6 Synthesis of deoxyharringtone
6.1 α-Ketoacids as coupling partners
6.2 Four-membered lactone intermediate as coupling partner
7 Synthesis of isoharringtonine, nordeoxyharringtonine and homoneoharringtonine
8 Conclusion

CLC Number: 

[1] (a) Huang L, Xue Z. The Alkaloids. NY:Academic Press, 1984. 157; (b) Hudlicky T, Kwart L D, Reed J W. Alkaloids Chemical and Biological Perspectives. NY:John Wiley and Sons, 1987. 639; (c) Jalil Miah M A, Hudlicky T, Reed J W. The Alkaloids. NY:Academic Press, 1998. 199; (d)何子乐(He Z L), 吴毓林(Wu Y L), 洪永叁(Hong Y S), 伍贻康(Wu Y K), 姚祝军(Yao Z J). 天然产物全合成荟萃-生物碱(Collection of Natural Products Total Synthesis-Alkaloids). 北京:科学出版社(Beijing:Science Press), 2009. 331; (e)曾步兵(Zeng B B), 任江萌(Ren J M). 药用天然产物全合成-合成路线精选(Medicinal Natural Products-Total Synthetic Approaches). 上海:华东理工大学出版社(Shanghai:East China University of Science and Technology Press), 2016. 88; (f)陈洋(Chen Y), 李卫东(Li W D Z). 有机化学(Chin. J. Org. Chem.), 2017, 37(8):1885.
[2] (a)中国药典, 1990年版二部, 1990. 588.; (b)中国药典, 2005年版二部, 2005. 629.; (c)中国药典, 2015年版二部, 2015. 1176.
[3] (a) Kantarjian H M, O'Brien S, Cortes J. Clin. Lymphoma Myeloma Leuk., 2013, 13:530; (b) Heiblig M, Sobh M, Nicolini F E. Leuk Res., 2014, 38:1145; (c)杨楠(Yang N), 孙红哲(Sun H Z). 化学进展(Prog. Chem.), 2009, 21(05):856.
[4] Hiranuma S, Shibata M, Hudlicky T. J. Org. Chem., 1983, 48:5321.
[5] Li X, Wang S, Dai J, Yan L, Zhao S, Wang J, Sun Y. European Journal of Pharmacology, 2017, 815:437.
[6] Pérard-Viret J, Quteishat L, Alsalim R, Royer J, Dumas F. The Alkaloids:Chemistry and Biology. NY:Academic Press, 2017. 205.
[7] Abdelkafi H, Nay B. Nat. Prod. Rep., 2012, 29:845.
[8] (a) Zhang Z W, Zhang X F, Feng J, Yang H, Wang C C, Feng J C, Liu S X. J. Org. Chem., 2013, 78:786; (b) Zhang ZW, Wang CC, Xue H, Dong Y, Yang JH, Liu S X, Liu WQ, Li WD Z. Org. Lett., 2018, 20:1050.
[9] 赵知中(Zhao Z Z), 席与珪(Xi Y G), 赵翰飞(Zhao H F), 侯建英(Hou J Y), 张建友(Zhang J Y), 王子厚(Wang Z H). 药学学报(Acta Pharmaceutica Sinica), 1980, 15(1):46.
[10] (a)王永铿(Wang Y K), 李裕林(Li Y L), 潘鑫复(Pan X F), 李绍白(Li S B), 黄文魁(Huang W K). 科学通报(Chin. Sci. Bull.), 1980, 25(12):576; (b)王永铿(Wang Y K), 李裕林(Li Y L), 潘鑫复(Pan X F), 李绍白(Li S B), 黄文魁(Huang W K). 化学学报(Acta Chimica Sinica), 1985, 43(2):161.
[11] Hiranuma S, Hudlicky T. Tetrahedron Lett., 1982, 23:3431.
[12] 程家宪(Cheng J X), 张建华(Zhang J H), 张千兵(Zhang Q B), 杨晶(Yang J), 黄量(Huang L). 药学学报(Acta Pharmaceutica Sinica), 1984, 19(3):178.
[13] 陈莉(Chen L), 李卫东(Li W D). CN 201110193584, 2011.
[14] Ma G Z, Li P F, Liu L, Li W D Z, Chen L. Org. Lett., 2017, 19:2250.
[15] Robin JP, Dhal R, Dujardin G, Girodier L, Mevellec L, Poutot S. Tetrahedron Lett., 1999, 40:2931.
[16] Ancliff R A, Russell A T, Sanderson A J. Chem. Commun., 2006, 3243.
[17] Marguerit M, Little G, Wang Y, He L, Allwein S, Reif J, Rossi J, Roemmele R, Bakale R. Eur. J. Org. Chem., 2015, 8003.
[18] (a) Eckelbarger J D, Wilmot J T, Gin D Y. J. Am. Chem. Soc., 2006, 128:10370; (b) Eckelbarger J D, Wilmot J T, Epperson M T, Thakur C S, Shum D, Antczak C, Tarassishin L, Djaballah H, Gin D Y. Chem. Eur. J., 2008, 14:4293.
[19] Mikolajczak K L, Smith C R Jr. J. Org. Chem., 1978, 43:4762.
[20] Huang L, Xi Y G, Guo J Y, Liu D K, Xu S P, Wu K M, Cheng J X, Jiang Y Z, Gao Y S, Guo Z R, Li L M, Zhang M Y, Chu F M. Scientia Sinica, 1979, 22:1333.
[21] Kelly T R, McNutt R W Jr, Montury M, Tosches N P. J. Org. Chem., 1979, 44:63.
[22] Berhal F, Tardy S, Pérard-Viret J, Royer J. Eur. J. Org. Chem., 2009, 437.
[23] El Bialy S A A, Braun H, Tietze L F. Eur. J. Org. Chem., 2005, 2965.
[24] 王永铿(Wang Y K), 穆启运(Mu Q Y), 李裕林(Li Y L), 潘鑫复(Pan X F), 黄文魁(Huang W K). 科学通报(Chin. Sci. Bull.), 1982, 27(14):576.
[25] 潘鑫复(Pan X F), 李裕林(Li Y L), 李绍白(Li S B), 田军(Tian J), 张大男(Zhang D N), 崔育新(Cui Y X), 成培贵(Cheng P G), 王永铿(Wang Y K), 黄文魁(Huang W K). 科学通报(Chin. Sci. Bull.), 1982, 27(17):576.
[26] (a) Keller L, Dumas F, d'Angelo J. Tetrahedron Lett. 2001, 42:1911; (b) Keller L, Dumas F, d'Angelo J. Eur. J. Org. Chem., 2003, 2488.
[27] Kelly T R, McKenna J C, Christenson P A. Tetrahedron Lett., 1973, 14, 3501.
[28] (a) Yang H, Sun M R, Zhao S G, Zhu M, Xie Y L, Niu C L, Li C L. J. Org. Chem., 2013, 78:339; (b)孙默然(Sun M R), 周航(Zhou H), 曹其伟(Cao Q W), 高凯哥(Gao K G), 杨华(Yang H). 化学研究(Chemical Research), 2013, 24(4):416; (c) Sun M R, Jia X, Lai Y W, Yang H. J. Chem. Res., 2015, 39:26.
[1] Mengrui Yang, Yuxin Xie, Dunru Zhu. Synthetic Strategies of Chemically Stable Metal-Organic Frameworks [J]. Progress in Chemistry, 2023, 35(5): 683-698.
[2] Wu Zhenyu,Zhang Yunhong,Wang Hui,Ma Fengqi. Research on Design and Synthesis of Cyclic Peptides [J]. Progress in Chemistry, 2002, 14(02): 113-.